EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE . Glob. j. public health med. 2026, 8 (1 (Ongoing), 216-227. https://doi.org/10.37557/33f44713.